Cargando…

Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?

Detalles Bibliográficos
Autores principales: McBride, Angela, Mehta, Puja, Rivino, Laura, Ramanan, Athimalaipet V, Yacoub, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057720/
https://www.ncbi.nlm.nih.gov/pubmed/33899037
http://dx.doi.org/10.1016/S2666-5247(21)00087-2
_version_ 1783680885119254528
author McBride, Angela
Mehta, Puja
Rivino, Laura
Ramanan, Athimalaipet V
Yacoub, Sophie
author_facet McBride, Angela
Mehta, Puja
Rivino, Laura
Ramanan, Athimalaipet V
Yacoub, Sophie
author_sort McBride, Angela
collection PubMed
description
format Online
Article
Text
id pubmed-8057720
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80577202021-04-21 Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought? McBride, Angela Mehta, Puja Rivino, Laura Ramanan, Athimalaipet V Yacoub, Sophie Lancet Microbe Comment The Author(s). Published by Elsevier Ltd. 2021-07 2021-04-20 /pmc/articles/PMC8057720/ /pubmed/33899037 http://dx.doi.org/10.1016/S2666-5247(21)00087-2 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
McBride, Angela
Mehta, Puja
Rivino, Laura
Ramanan, Athimalaipet V
Yacoub, Sophie
Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
title Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
title_full Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
title_fullStr Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
title_full_unstemmed Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
title_short Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
title_sort targeting hyperinflammation in infection: can we harness the covid-19 therapeutics momentum to end the dengue drugs drought?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057720/
https://www.ncbi.nlm.nih.gov/pubmed/33899037
http://dx.doi.org/10.1016/S2666-5247(21)00087-2
work_keys_str_mv AT mcbrideangela targetinghyperinflammationininfectioncanweharnessthecovid19therapeuticsmomentumtoendthedenguedrugsdrought
AT mehtapuja targetinghyperinflammationininfectioncanweharnessthecovid19therapeuticsmomentumtoendthedenguedrugsdrought
AT rivinolaura targetinghyperinflammationininfectioncanweharnessthecovid19therapeuticsmomentumtoendthedenguedrugsdrought
AT ramananathimalaipetv targetinghyperinflammationininfectioncanweharnessthecovid19therapeuticsmomentumtoendthedenguedrugsdrought
AT yacoubsophie targetinghyperinflammationininfectioncanweharnessthecovid19therapeuticsmomentumtoendthedenguedrugsdrought